Condition
Advanced Refractory Solid Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Advanced Refractory Solid Tumors clinical trials that are recruiting, at sites in 2 countries (most in China (1), Singapore (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Becotatug Vedotin Plus Pucotenlimab in EGFR-High Advanced Cancers
This phase II study tests whether combining Becotatug Vedotin with Pucotenlimab helps people whose advanced solid tumors express high EGFR.
-
Combining Selinexor and Talazoparib for Advanced Triple Negative Breast Cancer
This study is testing a combination of two drugs, Selinexor and Talazoparib, to see if they can help people with advanced triple negative breast cancer.
Related topics
Quick answers
How many Advanced Refractory Solid Tumors clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Singapore (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.